Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
eribulin (halaven) (1 trial)
Breast Neoplasms (Phase 4)
Drug-Related Side Effects and Adverse Reactions (Phase 4)
Trials (1 total)
Trial APIs (1 total)